AR008245A1 - DERIVATIVES OF ACETIC ACID, USE OF THE SAME IN THE MANUFACTURE OF A THERAPEUTIC AGENT AND PROCESS TO PREPARE SUCH DERIVATIVES - Google Patents

DERIVATIVES OF ACETIC ACID, USE OF THE SAME IN THE MANUFACTURE OF A THERAPEUTIC AGENT AND PROCESS TO PREPARE SUCH DERIVATIVES

Info

Publication number
AR008245A1
AR008245A1 ARP970102676A ARP970102676A AR008245A1 AR 008245 A1 AR008245 A1 AR 008245A1 AR P970102676 A ARP970102676 A AR P970102676A AR P970102676 A ARP970102676 A AR P970102676A AR 008245 A1 AR008245 A1 AR 008245A1
Authority
AR
Argentina
Prior art keywords
derivatives
prepare
manufacture
acetic acid
therapeutic agent
Prior art date
Application number
ARP970102676A
Other languages
Spanish (es)
Original Assignee
Glaxo Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB9613095.0A external-priority patent/GB9613095D0/en
Priority claimed from GBGB9613017.4A external-priority patent/GB9613017D0/en
Priority claimed from GBGB9613018.2A external-priority patent/GB9613018D0/en
Application filed by Glaxo Group Ltd filed Critical Glaxo Group Ltd
Publication of AR008245A1 publication Critical patent/AR008245A1/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D453/00—Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids
    • C07D453/02—Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids containing not further condensed quinuclidine ring systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

Compuestos de la fórmula (I) o una sal, solvato o derivado del mismo funcional fisiológicamente, en el cual: X representa ya sea CH2-CCCH2 o CH=CH;Y representa un grupo de fórmula (II); R0 representa SO2Me o CONH2, y R1 es SO2Me, a procesos para su preparación, a composicones farmacéuticas quecontienen tales compuestos y a su uso en la preparación de agentes para el tratamiento de desórdenes trombóticos.Compounds of formula (I) or a physiologically functional salt, solvate or derivative thereof, in which: X represents either CH2-CCCH2 or CH = CH, Y represents a group of formula (II); R0 represents SO2Me or CONH2, and R1 is SO2Me, to processes for their preparation, to pharmaceutical compositions containing such compounds and to their use in the preparation of agents for the treatment of thrombotic disorders.

ARP970102676A 1996-06-21 1997-06-18 DERIVATIVES OF ACETIC ACID, USE OF THE SAME IN THE MANUFACTURE OF A THERAPEUTIC AGENT AND PROCESS TO PREPARE SUCH DERIVATIVES AR008245A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB9613095.0A GB9613095D0 (en) 1996-06-21 1996-06-21 Therapeutic piperidines
GBGB9613017.4A GB9613017D0 (en) 1996-06-21 1996-06-21 Therapeutic compounds
GBGB9613018.2A GB9613018D0 (en) 1996-06-21 1996-06-21 Therapeutic indazoles

Publications (1)

Publication Number Publication Date
AR008245A1 true AR008245A1 (en) 1999-12-29

Family

ID=27268341

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP970102676A AR008245A1 (en) 1996-06-21 1997-06-18 DERIVATIVES OF ACETIC ACID, USE OF THE SAME IN THE MANUFACTURE OF A THERAPEUTIC AGENT AND PROCESS TO PREPARE SUCH DERIVATIVES

Country Status (17)

Country Link
EP (1) EP0912555A1 (en)
JP (1) JP2000512648A (en)
KR (1) KR20000022041A (en)
AP (1) AP9801417A0 (en)
AR (1) AR008245A1 (en)
AU (1) AU3261197A (en)
BR (1) BR9709930A (en)
CA (1) CA2258753A1 (en)
CZ (1) CZ424698A3 (en)
EA (1) EA199801015A1 (en)
ID (1) ID17052A (en)
IL (1) IL127464A0 (en)
IS (1) IS4924A (en)
NO (1) NO985974L (en)
PL (1) PL330797A1 (en)
TR (1) TR199802665T2 (en)
WO (1) WO1997049699A1 (en)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2003004488A1 (en) 2001-07-03 2003-01-16 Chiron Corporation Indazole benzimidazole compounds as tyrosine and serine/threonine kinase inhibitors
US7642278B2 (en) 2001-07-03 2010-01-05 Novartis Vaccines And Diagnostics, Inc. Indazole benzimidazole compounds
TW200401641A (en) * 2002-07-18 2004-02-01 Wyeth Corp 1-Heterocyclylalkyl-3-sulfonylindole or-indazole derivatives as 5-hydroxytryptamine-6 ligands
CA2515570A1 (en) * 2003-02-14 2004-09-02 Wyeth Heterocyclyl-3-sulfonylindazoles as 5-hydroxytryptamine-6 ligands
CN101432274A (en) 2006-04-05 2009-05-13 惠氏公司 Sulfonyl-3-heterocyclylindazole derivatives as 5-hydroxytryptamine-6 ligands
EP2118062A1 (en) 2007-01-10 2009-11-18 F. Hoffmann-Roche AG Sulfonamide derivatives as chymase inhibitors
CN113655155A (en) * 2021-07-28 2021-11-16 任贤金 Method for measuring SPH3127 related substances

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4124942A1 (en) * 1991-07-27 1993-01-28 Thomae Gmbh Dr K 5-LOW HETEROCYCLES, METHOD FOR THE PRODUCTION THEREOF AND MEDICAMENTS CONTAINING SUCH COMPOUNDS
EP0612313A1 (en) * 1991-11-14 1994-08-31 Glaxo Group Limited Piperidine acetic acid derivatives as inhibitors of fibrinogen-dependent blood platelet aggregation
GB9208740D0 (en) * 1992-04-23 1992-06-10 Glaxo Group Ltd Chemical compounds

Also Published As

Publication number Publication date
JP2000512648A (en) 2000-09-26
EA199801015A1 (en) 1999-08-26
BR9709930A (en) 1999-08-10
TR199802665T2 (en) 1999-03-22
NO985974D0 (en) 1998-12-18
AP9801417A0 (en) 1998-12-31
ID17052A (en) 1997-12-04
WO1997049699A1 (en) 1997-12-31
PL330797A1 (en) 1999-06-07
IL127464A0 (en) 1999-10-28
NO985974L (en) 1999-02-17
CA2258753A1 (en) 1997-12-31
IS4924A (en) 1998-12-15
EP0912555A1 (en) 1999-05-06
CZ424698A3 (en) 1999-05-12
AU3261197A (en) 1998-01-14
KR20000022041A (en) 2000-04-25

Similar Documents

Publication Publication Date Title
AR024060A1 (en) NEW PHARMACEUTICALLY ACTIVE COMPOUNDS
ES2123654T3 (en) CARBAPENEMS CONTAINING A PHENYL GROUP SUBSTITUTED WITH CARBOXI, PROCESSES FOR ITS PREPARATION, INTERMEDIATE PRODUCTS AND USE AS ANTIBIOTICS.
ES2145922T3 (en) USEFUL SPYRO-AZABICYCLIC COMPOUNDS IN THERAPY.
DK1140745T3 (en) Colchinol derivatives as vascular harmful agents
ES8604565A1 (en) A 6-fluoro-1,4-dihydro-4-oxo-7-substituted piperazinyl-quinoline-3-carboxylic acid derivative and the method for preparing the same.
SE7614258L (en) PROCEDURE FOR THE PREPARATION OF CHINAZOLO DERIVATIVE
LV12291A (en) Compound and pharmaceutical compositions for the treatment of related diseases by triptase activity
AR006401A1 (en) PIRROLOPYROLONE COMPOUNDS, A PHARMACEUTICAL COMPOSITION THAT CONTAINS THEM, ITS USE IN THE MANUFACTURE OF A MEDICINAL PRODUCT AND IN THERAPY, PROCESSES FOR ITS PREPARATION AND INTERMEDIARY COMPOUNDS FOR SUCH PROCESSES.
MX9204637A (en) NEW DERIVATIVES OF PIRAZINE AND PROCEDURE FOR ITS PREPARATION.
IT1170214B (en) PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OF PERIPHERAL ARTERIOPATHIES
ATE38988T1 (en) IMIDAZOLYLPHENYL-TETRAHYDROPYRIDAZINE, PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL PREPARATIONS CONTAINING THEM.
AR008245A1 (en) DERIVATIVES OF ACETIC ACID, USE OF THE SAME IN THE MANUFACTURE OF A THERAPEUTIC AGENT AND PROCESS TO PREPARE SUCH DERIVATIVES
EG19302A (en) Compound with gastric acid inhibitory effect and process for its preparation
ES427079A1 (en) Phenothiazine derivatives, compositions thereof and methods of preparation thereof
FI801769A (en) PAROMOMYCIN DERIVATIVES FOERFARANDE FOER DERAS FRAMSTAELLNING OCH THERAPEUTIC COMPOSITION DAER DE INGAOR
DK527186D0 (en) SOURCE CHODILATING PHARMACEUTICAL PREPARATION
ES471993A1 (en) Derivatives of pentacyclic alcaloids, method for their preparation, application in the synthesis of products of the eburnamonine group and pharmaceutical compositions.
DE2963010D1 (en) 3-chloro-6-hydroxy-5-methylbenzoic acid derivatives, corresponding pharmaceutical preparations, growth promoting compositions, the use of the compounds for promoting growth in certain animals and their manufacture
GT199900171A (en) ORAL SERTRALINE CONCENTRATE.
ES8802612A1 (en) Benzisoselenazolonyl derivatives, process for their preparation and pharmaceutical compositions containing them.
SE9900190D0 (en) New compounds
SE8402199L (en) PHARMACEUTICAL PREPARATION CONTAINING CO-DERGOCRIN AND A CALCIUM ANTAGONIST
AR005724A1 (en) BIOLOGICALLY ACTIVE UREID DERIVATIVES USEFUL IN THE TREATMENT OF MULTIPLE SCLEROSIS
DK0541726T3 (en) Growth factor compositions, preparation and application
GB1505525A (en) Pyridopyrimidines